조제 약국 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)

Compounding Pharmacy Market - Scope of Report

TMR's report on the global compounding pharmacy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global compounding pharmacy market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global compounding pharmacy market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the compounding pharmacy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global compounding pharmacy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global compounding pharmacy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global compounding pharmacy market.

The report delves into the competitive landscape of the global compounding pharmacy market. Key players operating in the global compounding pharmacy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global compounding pharmacy market profiled in this report.

Key Questions Answered in Global compounding pharmacy Market Report:

• What is the sales/revenue generated by compounding pharmacy across all regions during the forecast period?
• What are the opportunities in the global compounding pharmacy market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Compounding Pharmacy Market - Research Objectives and Research Approach

The comprehensive report on the global compounding pharmacy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global compounding pharmacy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global compounding pharmacy market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Compounding Pharmacy Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
  • 4.1.2. Industry Evolution / Developments
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Compounding Pharmacy Market Analysis and Forecasts, 2020-2034
  • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

• 5.1. Technological Advancements that assist Pharmaceutical Compounding
• 5.2. Insights on In-house and Outsourced Pharmaceutical Compounding
• 5.3. Discussion on Benefits and Potential Risks of Pharmaceutical Compounding
• 5.4. List of Compounding Pharmacies across Key Region / Countries
• 5.5. Regulatory Scenario across Key Regions / Countries
• 5.6. PORTER's Five Forces Analysis
• 5.7. PESTEL Analysis
• 5.8. Value Chain Analysis
• 5.9. Go-to-Market Strategy for New Market Entrants
• 5.10. Key Industry Events

6. Global Compounding Pharmacy Market Analysis and Forecasts, By Pharmacy Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Pharmacy Type, 2020-2034
  • 6.3.1. 503A Pharmacies
  • 6.3.2. 503B Pharmacies
• 6.4. Market Attractiveness By Pharmacy Type

7. Global Compounding Pharmacy Market Analysis and Forecasts, By Compounding Type

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Compounding Type, 2020-2034
  • 7.3.1. Pharmaceutical Ingredient Alteration (PIA)
  • 7.3.2. Drug Shortage Manufacturing
  • 7.3.3. Pharmaceutical Dosage Alteration (PDA)
• 7.4. Market Attractiveness By Compounding Type

8. Global Compounding Pharmacy Market Analysis and Forecasts, By Sterility

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By Sterility, 2020-2034
  • 8.3.1. Sterile
  • 8.3.2. Non-sterile
• 8.4. Market Attractiveness By Sterility

9. Global Compounding Pharmacy Market Analysis and Forecasts, By Dosage Form

• 9.1. Introduction & Definition
• 9.2. Key Findings / Developments
• 9.3. Market Value Forecast By Dosage Form, 2020-2034
  • 9.3.1. Oral Medications
    • 9.3.1.1. Capsules
    • 9.3.1.2. Tablets
    • 9.3.1.3. Suspensions
    • 9.3.1.4. Others (Chewables, etc.)
  • 9.3.2. Topical Medications
    • 9.3.2.1. Creams
    • 9.3.2.2. Gels
    • 9.3.2.3. Ointments
    • 9.3.2.4. Others (Paste, etc.)
  • 9.3.3. Injectables
  • 9.3.4. Suppositories
  • 9.3.5. Others
• 9.4. Market Attractiveness By Dosage Form

10. Global Compounding Pharmacy Market Analysis and Forecasts, By Application

• 10.1. Introduction & Definition
• 10.2. Key Findings / Developments
• 10.3. Market Value Forecast By Application, 2020-2034
  • 10.3.1. Hormone Replacement Therapy
  • 10.3.2. Pain Management
  • 10.3.3. Neurology
  • 10.3.4. Dermatology
  • 10.3.5. Ophthalmology
  • 10.3.6. Nutritional Supplements
  • 10.3.7. Others (ENT, Thyroid Disorders, etc.)
• 10.4. Market Attractiveness By Application

11. Global Compounding Pharmacy Market Analysis and Forecasts, By Patient Demographics

• 11.1. Introduction & Definition
• 11.2. Key Findings / Developments
• 11.3. Market Value Forecast By Patient Demographics, 2020-2034
  • 11.3.1. Human
    • 11.3.1.1. Pediatric
    • 11.3.1.2. Adult
    • 11.3.1.3. Geriatric
  • 11.3.2. Veterinary
• 11.4. Market Attractiveness By Patient Demographics

12. Global Compounding Pharmacy Market Analysis and Forecasts, By Region

• 12.1. Key Findings
• 12.2. Market Value Forecast By Region
  • 12.2.1. North America
  • 12.2.2. Europe
  • 12.2.3. Asia Pacific
  • 12.2.4. Latin America
  • 12.2.5. Middle East & Africa
• 12.3. Market Attractiveness By Country/Region

13. North America Compounding Pharmacy Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Pharmacy Type, 2020-2034
  • 13.2.1. 503A Pharmacies
  • 13.2.2. 503B Pharmacies
• 13.3. Market Value Forecast By Compounding Type, 2020-2034
  • 13.3.1. Pharmaceutical Ingredient Alteration (PIA)
  • 13.3.2. Drug Shortage Manufacturing
  • 13.3.3. Pharmaceutical Dosage Alteration (PDA)
• 13.4. Market Value Forecast By Sterility, 2020-2034
  • 13.4.1. Sterile
  • 13.4.2. Non-sterile
• 13.5. Market Value Forecast By Dosage Form, 2020-2034
  • 13.5.1. Oral Medications
    • 13.5.1.1. Capsules
    • 13.5.1.2. Tablets
    • 13.5.1.3. Suspensions
    • 13.5.1.4. Others (Chewables, etc.)
  • 13.5.2. Topical Medications
    • 13.5.2.1. Creams
    • 13.5.2.2. Gels
    • 13.5.2.3. Ointments
    • 13.5.2.4. Others (Paste, etc.)
  • 13.5.3. Injectables
  • 13.5.4. Suppositories
  • 13.5.5. Others
• 13.6. Market Value Forecast By Application, 2020-2034
  • 13.6.1. Hormone Replacement Therapy
  • 13.6.2. Pain Management
  • 13.6.3. Neurology
  • 13.6.4. Dermatology
  • 13.6.5. Ophthalmology
  • 13.6.6. Nutritional Supplements
  • 13.6.7. Others (ENT, Thyroid Disorders, etc.)
• 13.7. Market Value Forecast By Patient Demographics, 2020-2034
  • 13.7.1. Human
    • 13.7.1.1. Pediatric
    • 13.7.1.2. Adult
    • 13.7.1.3. Geriatric
  • 13.7.2. Veterinary
• 13.8. Market Value Forecast By Country, 2020-2034
  • 13.8.1. U.S.
  • 13.8.2. Canada
• 13.9. Market Attractiveness Analysis
  • 13.9.1. By Pharmacy Type
  • 13.9.2. By Compounding Type
  • 13.9.3. By Sterility
  • 13.9.4. By Dosage Form
  • 13.9.5. By Application
  • 13.9.6. By Patient Demographics
  • 13.9.7. By Country

14. Europe Compounding Pharmacy Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Pharmacy Type, 2020-2034
  • 14.2.1. 503A Pharmacies
  • 14.2.2. 503B Pharmacies
• 14.3. Market Value Forecast By Compounding Type, 2020-2034
  • 14.3.1. Pharmaceutical Ingredient Alteration (PIA)
  • 14.3.2. Drug Shortage Manufacturing
  • 14.3.3. Pharmaceutical Dosage Alteration (PDA)
• 14.4. Market Value Forecast By Sterility, 2020-2034
  • 14.4.1. Sterile
  • 14.4.2. Non-sterile
• 14.5. Market Value Forecast By Dosage Form, 2020-2034
  • 14.5.1. Oral Medications
    • 14.5.1.1. Capsules
    • 14.5.1.2. Tablets
    • 14.5.1.3. Suspensions
    • 14.5.1.4. Others (Chewables, etc.)
  • 14.5.2. Topical Medications
    • 14.5.2.1. Creams
    • 14.5.2.2. Gels
    • 14.5.2.3. Ointments
    • 14.5.2.4. Others (Paste, etc.)
  • 14.5.3. Injectables
  • 14.5.4. Suppositories
  • 14.5.5. Others
• 14.6. Market Value Forecast By Application, 2020-2034
  • 14.6.1. Hormone Replacement Therapy
  • 14.6.2. Pain Management
  • 14.6.3. Neurology
  • 14.6.4. Dermatology
  • 14.6.5. Ophthalmology
  • 14.6.6. Nutritional Supplements
  • 14.6.7. Others (ENT, Thyroid Disorders, etc.)
• 14.7. Market Value Forecast By Patient Demographics, 2020-2034
  • 14.7.1. Human
    • 14.7.1.1. Pediatric
    • 14.7.1.2. Adult
    • 14.7.1.3. Geriatric
  • 14.7.2. Veterinary
• 14.8. Market Value Forecast By Country/Sub-region, 2020-2034
  • 14.8.1. Germany
  • 14.8.2. U.K.
  • 14.8.3. France
  • 14.8.4. Italy
  • 14.8.5. Spain
  • 14.8.6. Rest of Europe
• 14.9. Market Attractiveness Analysis
  • 14.9.1. By Pharmacy Type
  • 14.9.2. By Compounding Type
  • 14.9.3. By Sterility
  • 14.9.4. By Dosage Form
  • 14.9.5. By Application
  • 14.9.6. By Patient Demographics
  • 14.9.7. By Country/Sub-region

15. Asia Pacific Compounding Pharmacy Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast By Pharmacy Type, 2020-2034
  • 15.2.1. 503A Pharmacies
  • 15.2.2. 503B Pharmacies
• 15.3. Market Value Forecast By Compounding Type, 2020-2034
  • 15.3.1. Pharmaceutical Ingredient Alteration (PIA)
  • 15.3.2. Drug Shortage Manufacturing
  • 15.3.3. Pharmaceutical Dosage Alteration (PDA)
• 15.4. Market Value Forecast By Sterility, 2020-2034
  • 15.4.1. Sterile
  • 15.4.2. Non-sterile
• 15.5. Market Value Forecast By Dosage Form, 2020-2034
  • 15.5.1. Oral Medications
    • 15.5.1.1. Capsules
    • 15.5.1.2. Tablets
    • 15.5.1.3. Suspensions
    • 15.5.1.4. Others (Chewables, etc.)
  • 15.5.2. Topical Medications
    • 15.5.2.1. Creams
    • 15.5.2.2. Gels
    • 15.5.2.3. Ointments
    • 15.5.2.4. Others (Paste, etc.)
  • 15.5.3. Injectables
  • 15.5.4. Suppositories
  • 15.5.5. Others
• 15.6. Market Value Forecast By Application, 2020-2034
  • 15.6.1. Hormone Replacement Therapy
  • 15.6.2. Pain Management
  • 15.6.3. Neurology
  • 15.6.4. Dermatology
  • 15.6.5. Ophthalmology
  • 15.6.6. Sports Medicine
  • 15.6.7. Nutritional Supplements
  • 15.6.8. Others (ENT, Thyroid Disorders, etc.)
• 15.7. Market Value Forecast By Patient Demographics, 2020-2034
  • 15.7.1. Human
    • 15.7.1.1. Pediatric
    • 15.7.1.2. Adult
    • 15.7.1.3. Geriatric
  • 15.7.2. Veterinary
• 15.8. Market Value Forecast By Country/Sub-region, 2020-2034
  • 15.8.1. China
  • 15.8.2. India
  • 15.8.3. Japan
  • 15.8.4. Australia & New Zealand
  • 15.8.5. Rest of Asia Pacific
• 15.9. Market Attractiveness Analysis
  • 15.9.1. By Pharmacy Type
  • 15.9.2. By Compounding Type
  • 15.9.3. By Sterility
  • 15.9.4. By Dosage Form
  • 15.9.5. By Application
  • 15.9.6. By Patient Demographics
  • 15.9.7. By Country/Sub-region

16. Latin America Compounding Pharmacy Market Analysis and Forecast

• 16.1. Introduction
  • 16.1.1. Key Findings
• 16.2. Market Value Forecast By Pharmacy Type, 2020-2034
  • 16.2.1. 503A Pharmacies
  • 16.2.2. 503B Pharmacies
• 16.3. Market Value Forecast By Compounding Type, 2020-2034
  • 16.3.1. Pharmaceutical Ingredient Alteration (PIA)
  • 16.3.2. Drug Shortage Manufacturing
  • 16.3.3. Pharmaceutical Dosage Alteration (PDA)
• 16.4. Market Value Forecast By Sterility, 2020-2034
  • 16.4.1. Sterile
  • 16.4.2. Non-sterile
• 16.5. Market Value Forecast By Dosage Form, 2020-2034
  • 16.5.1. Oral Medications
    • 16.5.1.1. Capsules
    • 16.5.1.2. Tablets
    • 16.5.1.3. Suspensions
    • 16.5.1.4. Others (Chewables, etc.)
  • 16.5.2. Topical Medications
    • 16.5.2.1. Creams
    • 16.5.2.2. Gels
    • 16.5.2.3. Ointments
    • 16.5.2.4. Others (Paste, etc.)
  • 16.5.3. Injectables
  • 16.5.4. Suppositories
  • 16.5.5. Others
• 16.6. Market Value Forecast By Application, 2020-2034
  • 16.6.1. Hormone Replacement Therapy
  • 16.6.2. Pain Management
  • 16.6.3. Neurology
  • 16.6.4. Dermatology
  • 16.6.5. Ophthalmology
  • 16.6.6. Nutritional Supplements
  • 16.6.7. Others (ENT, Thyroid Disorders, etc.)
• 16.7. Market Value Forecast By Patient Demographics, 2020-2034
  • 16.7.1. Human
    • 16.7.1.1. Pediatric
    • 16.7.1.2. Adult
    • 16.7.1.3. Geriatric
  • 16.7.2. Veterinary
• 16.8. Market Value Forecast By Country/Sub-region, 2020-2034
  • 16.8.1. Brazil
  • 16.8.2. Mexico
  • 16.8.3. Rest of Latin America
• 16.9. Market Attractiveness Analysis
  • 16.9.1. By Pharmacy Type
  • 16.9.2. By Compounding Type
  • 16.9.3. By Sterility
  • 16.9.4. By Dosage Form
  • 16.9.5. By Application
  • 16.9.6. By Patient Demographics
  • 16.9.7. By Country/Sub-region

17. Middle East & Africa Compounding Pharmacy Market Analysis and Forecast

• 17.1. Introduction
  • 17.1.1. Key Findings
• 17.2. Market Value Forecast By Pharmacy Type, 2020-2034
  • 17.2.1. 503A Pharmacies
  • 17.2.2. 503B Pharmacies
• 17.3. Market Value Forecast By Compounding Type, 2020-2034
  • 17.3.1. Pharmaceutical Ingredient Alteration (PIA)
  • 17.3.2. Drug Shortage Manufacturing
  • 17.3.3. Pharmaceutical Dosage Alteration (PDA)
• 17.4. Market Value Forecast By Sterility, 2020-2034
  • 17.4.1. Sterile
  • 17.4.2. Non-sterile
• 17.5. Market Value Forecast By Dosage Form, 2020-2034
  • 17.5.1. Oral Medications
    • 17.5.1.1. Capsules
    • 17.5.1.2. Tablets
    • 17.5.1.3. Suspensions
    • 17.5.1.4. Others (Chewables, etc.)
  • 17.5.2. Topical Medications
    • 17.5.2.1. Creams
    • 17.5.2.2. Gels
    • 17.5.2.3. Ointments
    • 17.5.2.4. Others (Paste, etc.)
  • 17.5.3. Injectables
  • 17.5.4. Suppositories
  • 17.5.5. Others
• 17.6. Market Value Forecast By Application, 2020-2034
  • 17.6.1. Hormone Replacement Therapy
  • 17.6.2. Pain Management
  • 17.6.3. Neurology
  • 17.6.4. Dermatology
  • 17.6.5. Ophthalmology
  • 17.6.6. Nutritional Supplements
  • 17.6.7. Others (ENT, Thyroid Disorders, etc.)
• 17.7. Market Value Forecast By Patient Demographics, 2020-2034
  • 17.7.1. Human
    • 17.7.1.1. Pediatric
    • 17.7.1.2. Adult
    • 17.7.1.3. Geriatric
  • 17.7.2. Veterinary
• 17.8. Market Value Forecast By Country/Sub-region, 2020-2034
  • 17.8.1. GCC Countries
  • 17.8.2. South Africa
  • 17.8.3. Rest of Middle East & Africa
• 17.9. Market Attractiveness Analysis
  • 17.9.1. By Pharmacy Type
  • 17.9.2. By Compounding Type
  • 17.9.3. By Sterility
  • 17.9.4. By Dosage Form
  • 17.9.5. By Application
  • 17.9.6. By Patient Demographics
  • 17.9.7. By Country/Sub-region

18. Competition Landscape

• 18.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 18.2. Market Share Analysis By Company (2023)
• 18.3. Company Profiles
  • 18.3.1. B. Braun SE
    • 18.3.1.1. Company Overview
    • 18.3.1.2. Financial Overview
    • 18.3.1.3. Financial Overview
    • 18.3.1.4. Business Strategies
    • 18.3.1.5. Recent Developments
  • 18.3.2. WEDGEWOOD PHARMACY
    • 18.3.2.1. Company Overview
    • 18.3.2.2. Financial Overview
    • 18.3.2.3. Financial Overview
    • 18.3.2.4. Business Strategies
    • 18.3.2.5. Recent Developments
  • 18.3.3. Fagron
    • 18.3.3.1. Company Overview
    • 18.3.3.2. Financial Overview
    • 18.3.3.3. Financial Overview
    • 18.3.3.4. Business Strategies
    • 18.3.3.5. Recent Developments
  • 18.3.4. Fresenius Kabi AG
    • 18.3.4.1. Company Overview
    • 18.3.4.2. Financial Overview
    • 18.3.4.3. Financial Overview
    • 18.3.4.4. Business Strategies
    • 18.3.4.5. Recent Developments
  • 18.3.5. Avella Specialty Pharmacy
    • 18.3.5.1. Company Overview
    • 18.3.5.2. Financial Overview
    • 18.3.5.3. Financial Overview
    • 18.3.5.4. Business Strategies
    • 18.3.5.5. Recent Developments
  • 18.3.6. Aurora Health Care
    • 18.3.6.1. Company Overview
    • 18.3.6.2. Financial Overview
    • 18.3.6.3. Financial Overview
    • 18.3.6.4. Business Strategies
    • 18.3.6.5. Recent Developments
  • 18.3.7. Walgreen Co.
    • 18.3.7.1. Company Overview
    • 18.3.7.2. Financial Overview
    • 18.3.7.3. Financial Overview
    • 18.3.7.4. Business Strategies
    • 18.3.7.5. Recent Developments
  • 18.3.8. Formul8
    • 18.3.8.1. Company Overview
    • 18.3.8.2. Financial Overview
    • 18.3.8.3. Financial Overview
    • 18.3.8.4. Business Strategies
    • 18.3.8.5. Recent Developments
  • 18.3.9. Triangle Compounding
    • 18.3.9.1. Company Overview
    • 18.3.9.2. Financial Overview
    • 18.3.9.3. Financial Overview
    • 18.3.9.4. Business Strategies
    • 18.3.9.5. Recent Developments
  • 18.3.10. Apollo Clinical Pharmacy
    • 18.3.10.1. Company Overview
    • 18.3.10.2. Financial Overview
    • 18.3.10.3. Financial Overview
    • 18.3.10.4. Business Strategies
    • 18.3.10.5. Recent Developments
  • 18.3.11. The London Specialist Pharmacy Ltd
    • 18.3.11.1. Company Overview
    • 18.3.11.2. Financial Overview
    • 18.3.11.3. Financial Overview
    • 18.3.11.4. Business Strategies
    • 18.3.11.5. Recent Developments
  • 18.3.12. Olympia Pharmacy
    • 18.3.12.1. Company Overview
    • 18.3.12.2. Financial Overview
    • 18.3.12.3. Financial Overview
    • 18.3.12.4. Business Strategies
    • 18.3.12.5. Recent Developments
  • 18.3.13. Fusion Apothecary
    • 18.3.13.1. Company Overview
    • 18.3.13.2. Financial Overview
    • 18.3.13.3. Financial Overview
    • 18.3.13.4. Business Strategies
    • 18.3.13.5. Recent Developments
  • 18.3.14. Albertsons Companies, Inc.
    • 18.3.14.1. Company Overview
    • 18.3.14.2. Financial Overview
    • 18.3.14.3. Financial Overview
    • 18.3.14.4. Business Strategies
    • 18.3.14.5. Recent Developments
  • 18.3.15. JL Diekman and AQ Touchard
    • 18.3.15.1. Company Overview
    • 18.3.15.2. Financial Overview
    • 18.3.15.3. Financial Overview
    • 18.3.15.4. Business Strategies
    • 18.3.15.5. Recent Developments
  • 18.3.16. Roseway Labs
    • 18.3.16.1. Company Overview
    • 18.3.16.2. Financial Overview
    • 18.3.16.3. Financial Overview
    • 18.3.16.4. Business Strategies
    • 18.3.16.5. Recent Developments
  • 18.3.17. Hill's Compounding Pharmacy and Milford Pharmacy
    • 18.3.17.1. Company Overview
    • 18.3.17.2. Financial Overview
    • 18.3.17.3. Financial Overview
    • 18.3.17.4. Business Strategies
    • 18.3.17.5. Recent Developments
  • 18.3.18. Other Prominent Players
    • 18.3.18.1. Company Overview
    • 18.3.18.2. Financial Overview
    • 18.3.18.3. Financial Overview
    • 18.3.18.4. Business Strategies
    • 18.3.18.5. Recent Developments